NCT02054429View on ClinicalTrials.gov

Intensive Insulin Therapy With Tight Glycemic Control to Improve Outcomes After Endovascular Therapy for Acute Ischemic Stroke

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Ischemic Stroke
Interventions
DRUG

Insulin

Intensive Insulin Therapy (IIT) will be given to you by two IV infusions. The insulin infusion will be started immediately after you are moved to the intensive care unit (ICU) after endovascular therapy and continued for 48 hours

Trial Locations (1)

14203

University of Buffalo Neurosurgery, Buffalo

All Listed Sponsors
lead

University at Buffalo

OTHER

NCT02054429 - Intensive Insulin Therapy With Tight Glycemic Control to Improve Outcomes After Endovascular Therapy for Acute Ischemic Stroke | Biotech Hunter | Biotech Hunter